May 6, 2025 04:01PM

Feb 19, 2025 07:13AM

Feb 18, 2025 08:07AM

Feb 18, 2025 08:00AM

Mar 14, 2023 08:30AM

Mar 14, 2023 08:30AM

Mar 14, 2023 08:30AM Ultragenyx Appoints Dr. Eric Crombez Chief Medical Officer and Executive Vice President

Dec 18, 2020 09:22AM

Dec 17, 2020 05:37PM

Feb 13, 2020 04:01PM

Feb 13, 2020 04:01PM

Jan 13, 2020 08:20AM

Jan 13, 2020 08:10AM

Jan 13, 2020 08:10AM Ultragenyx Reports Preliminary 2019 Revenue and Provides 2020 Crysvita Revenue Guidance

Nov 5, 2019 04:01PM

Nov 5, 2019 04:01PM

Oct 14, 2019 08:32AM

Oct 14, 2019 08:30AM

Oct 14, 2019 08:30AM

Nov 14, 2018 08:31AM

Nov 14, 2018 08:30AM Ultragenyx Announces Intent to Submit New Drug Application to U.S. FDA for UX007 for the Treatment of Long-chain Fatty Acid Oxidation Disorders in Mid-2019

Feb 20, 2018 04:05PM

Feb 20, 2018 04:05PM

Nov 2, 2017 04:05PM

Nov 1, 2017 08:41AM

Nov 1, 2017 08:30AM

Oct 10, 2017 08:32AM

Oct 10, 2017 08:30AM Ultragenyx and Kyowa Hakko Kirin Announce FDA Acceptance and Priority Review Designation of Burosumab’s Biologics License Application

Jul 27, 2017 04:05PM

15,404 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All